In vitro modulation of macrophage phenotype and inhibition of polymer degradation by dexamethasone in a human macrophage/Fe/stress system

Journal of Biomedical Materials Research

Volumn 46, Issue 4, 1999, Pages 475-484

  Casas, J ^a   Zhao, Q ^a,b   Donovan, M ^a   Schroeder, P ^a   Stokes, K ^a   Untereker, D ^a  

^a MEDTRONIC INC   (United States)

^b Bio Vascular Inc   (United States)

Author keywords

Biodegradation; Dexamethasone; ESC; Macrophages; Oxidation; Polyurethane

Indexed keywords

DEXAMETHASONE; FERROUS CHLORIDE; POLYETHERURETHAN; POLYMER;

ARTICLE; BIODEGRADATION; CELL STRUCTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MATERIALS TESTING; OXIDATIVE STRESS; PHENOTYPE; RESPIRATORY BURST;

ADULT; BIODEGRADATION, ENVIRONMENTAL; CELL ADHESION; CELLS, CULTURED; DEXAMETHASONE; FERROUS COMPOUNDS; HUMANS; HYDROGEN PEROXIDE; MACROPHAGES; MATERIALS TESTING; MICROSCOPY, ELECTRON, SCANNING; OXIDATIVE STRESS; PHENOTYPE; POLYURETHANES; SURFACE PROPERTIES;

EID: 0033567864     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4636(19990915)46:4<475::AID-JBM5>3.0.CO;2-J     Document Type: Article

References (33)

1. Pinchuk L. A review of the biostability and carcinogenicity of polyurethanes in medicine and the new generation of "biostable" polyurethanes. J Biomater Sci Polym Ed 1994;6(3):225-267.
2. Stokes K, McVenes R, Anderson JM. Polyurethane elastomer biostability. J Biomater Appl 1995;9:321-354.
3. Stokes K. Biodegradation. Cardiovasc Pathol 1993;2(Suppl): 111S-119S.
4. Smith R, Williams DF, Oliver C. The biodegradation of poly(ether urethanes). J Biomed Mater Res 1987;21:1149.
5. Anderson JM, Inflammatory response to implants. Trans Am Soc Artif Intern Organs 1988;34:101.
6. Labow RS, Erfle DJ, Santerre JP. Neutrophil-mediated degradation of segmented polyurethanes. Biomaterials 1995;16:51-59.
7. Szycher M, Reed AM, Siciliano AA. In vivo testing of a biostable polyurethane. J Biomater Appl 1991;6:110-130.
8. Zhao Q, Topham N, Anderson JM, Hiltner A, Lodoen G, Payet CR. Foreign-body giant cells and polyurethane biostability: In vivo correlation of cell adhesion and surface cracking. J Biomed Mater Res 1991;25:177.
9. Santerre JP, Labow RS, Adams GA. Enzyme-biomaterial interactions: Effect of biosystems on degradation of polyurethanes. J Biomed Mater Res 1993;27:97.
10. Labow RS, Santerre JP, Waghray G. The effect of phospholipids on the biodegradation of polyurethanes by lysosomal enzymes. J Biomater Sei Polym Ed 1997;8:779-795.
11. 2 test system for in vitro evaluation of biodegradative stress cracking in polyurethane elastomers. J Biomed Mater Res 1995;29:467-475.
12. Collier T, Tan J, Shive M, Hasan S, Hiltner A, Anderson J. Biocompatibility of poly(etherurethane urea) containing dehydroepiandrosterone. J Biomed Mater Res 1998;41:192-201.
13. Casas J, Zhao Q, Donovan M, Untereker D. In vitro macrophage/iron/stress system for the study of PEU biodegradation. Trans Am Chem Soc Polym Mater Sci Eng 1998;79:512-513.
14. Anderson JM. Mechanisms of inflammation and infection with implanted devices. Cardiovasc Pathol 1993;2, No. 3(Suppl): 33S-41S.
15. El-Hag A, Clark RA. Intact natural killer activity in chronic granulomatous disease: Evidence against an oxygen-dependent cytotoxic mechanism. J Immunol 1984;132:569-570.
16. Boyum A, Louhaug D, Tresland L. Density-dependent separation of white blood cells. In: Blood separation and plasma fractionation. New York: Wiley-Liss; 1991. p 217-239.
17. Fujimoto K, Takebayashy Y, Inoue H, Ikada Y. Ozone-induced graft polymerization onto polymer surface. J Polym Chem 1993;31:1035-1043.
18. Byrd CL. Management of implant complications. In: Ellenbogen KA, Kay GN, Wilkoff BL, editors. Clinical cardiac pacing. Philadelphia: WB Saunders; 1995. p 491-522.
19. Sies H, editor. Oxidative stress. II: Oxidants and antioxidants. New York: Academic Press; 1991. 650 p.
20. Southern PA, Powis G. Free radicals in medicine. II. Involvement in human disease. Mayo Clin Proc 1988;63:390-408.
21. Grisham MB. Oxidant and free radicals in inflammmatory bowel disease. Lancet 1994;344:859-861.
22. Witstum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994;344:793-795.
23. Cerutti PA. Oxy-radicals and cancer. Lancet 1994;344:862-863.
24. Jennes P. Oxidative damage in neurodegenerative disease. 1994;344:796-798.
25. Kim K-B, Chung HH, Kim MS, Rho JR. Changes in the anti-oxidative defensive system during open heart operation in humans. Ann Thorac Surg 1994;58:170-175.
26. Grech ED, Dodd NJF, Bellamy CM, Perry RA, Morrison WL, Ramsdale DR. Free-radical generation during angioplasty reperfusion for acute myocardial infarction. Lancet 1993;341: 990-991.
27. Edelman ER. Vessel size, antioxidants, and restenosis: Never too small, not too little, but often too late. Circulation 1998;97: 416-420.
28. Halliwell B. Free radicals, antioxidants, and human disease: Curiosity, cause or consequence? Lancet 1994;344:721-724.
29. Alderson E, Birchall JP, Owen JJ. A simple method of lymphocyte purification from human peripheral blood. J Immunol Methods 1976;11:297-301.
30. Marchant RE, Miller KM, Anderson JM. In vivo biocompatibility studies. V. In vivo leukocyte interactions with Biomer. J Biomed Mater Res 1984;18:1169-1190.
31. Henson PM. Mechanisms of exocytosis in phagocytic inflammatory cells. Am J Pathol 1980;101:494-511.
32. Schubert MA, Wiggins MJ, Schaefer MP, Hiltner A, Anderson JM. Oxidative biodegradation mechanisms of biaxially strained poly(etherurethane urea) elastomers. J Biomed Mater Res 1995;29:337-347.
33. Grisham MB. Reactive oxygen metabolites of oxygen and nitrogen in biology and medicine. Austin, TX: RG Landes Bioscience; 1992. 115 p.